HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity (Q44925927)

7 December 2017

HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity (English)

1 reference

7 December 2017

Frédéric Reynard

1

1 reference

7 December 2017

Ahmed Fatmi

series ordinal

2

1 reference

7 December 2017

Bernard Verrier

series ordinal

3

1 reference

7 December 2017

Frédéric Bedin

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

7 December 2017

1 reference

7 December 2017

324

1 reference

7 December 2017

1

1 reference

7 December 2017

90-102

1 reference

Comparison of complete env gene sequences from individuals with symptomatic primary HIV type 1 infection.

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Immunoglobulin G (IgG) and IgA, but also nonantibody factors, account for in vitro neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by serum and plasma of HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Antibody and virus: binding and neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Functions of HIV envelope glycans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Conserved, N-linked carbohydrates of human immunodeficiency virus type 1 gp41 are largely dispensable for viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

The entire SU subunit is required for the incorporation of the HIV-1 envelope glycoprotein complex into virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Maturation of HIV envelope glycoprotein precursors by cellular endoproteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Processing and routage of HIV glycoproteins by furin to the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Importance of the N-glycan in the V3 loop of HIV-1 envelope protein for CXCR-4- but not CCR-5-dependent fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Antibody neutralization and escape by HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Erratum: Antibody neutralization and escape by HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

7 January 2021

Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

7 January 2021

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

7 January 2021

Association of human immunodeficiency virus type 1 envelope glycoprotein with particles depends on interactions between the third variable and conserved regions of gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

7 January 2021

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.03.022

7 January 2021

10.1016/J.VIROL.2004.03.022

Identifiers

DOI

1 reference

7 December 2017

1 reference